Abbreviations: {#nomen0010}
==============

4V

:   fourth ventricle

7

:   facial nucleus

7n

:   facial nerve

8n

:   vestibulocochlear nerve

12

:   hypoglossal nucleus

Aq

:   aqueduct

BAC

:   bacterial artificial chromosome

β-gal

:   β-galactosidase

Cre

:   Cre recombinase

DAPI

:   4′,6-diamidino-2-phenylindole dihydrochloride

DC

:   dorsal cochlear nucleus

DIG

:   digoxigenin

DTg

:   dorsal tegmental nucleus

EGFP

:   enhanced green fluorescent protein

GC

:   granule cell layer

Gi

:   gigantocellular reticular nucleus

GiA

:   gigantocellular reticular nucleus, alpha part

GLYT

:   glycine transporter

GLYT1

:   glycine transporter 1

GLYT2

:   glycine transporter 2

GM

:   gray matter

Gr

:   granular layer

IC

:   inferior colliculus

icp

:   inferior cerebellar peduncle

Int

:   interposed cerebellar nucleus

IO

:   inferior olive

Lat

:   lateral cerebellar nucleus

MdD

:   medullary reticular nucleus, dorsal part

MdV

:   medullary reticular nucleus, ventral part

Mo

:   molecular layer

MVe

:   medial vestibular nucleus

neo

:   neomycin-resistant gene expression cassette

Pa4

:   paratrochlear nucleus

PBS

:   phosphate-buffered saline

PC

:   Purkinje cell layer

Pn

:   pontine nuclei

PnC

:   pontine reticular nucleus, caudal part

PnO

:   pontine reticular nucleus, oral part

Pr

:   prepositus nucleus

Pr5

:   principal sensory trigeminal nucleus

py

:   pyramidal tract

RMg

:   raphe magnus nucleus

SC

:   superior colliculus

SO

:   superior olive

SP5

:   spinal trigeminal nucleus

TBS

:   Tris-buffered saline

TBST

:   TBS containing 0.1% Tween-20

Tz

:   nucleus of the trapezoid body

VC

:   ventral cochlear nucleus

VLL

:   ventral nucleus of the lateral lemniscus

WM

:   white matter

1. Introduction {#sec1}
===============

Glycine is a major inhibitory neurotransmitter in the brainstem and spinal cord, and glycinergic neurotransmission participates in a variety of functions, such as sensory processing, motor rhythm generation, and control of the respiratory network ([@bib16], [@bib7], [@bib32]). Glycine is released from presynaptic terminals in glycinergic neurons through a vesicular mechanism ([@bib29]; [@bib25]) and acts on postsynaptic glycine receptors (GlyRs) ([@bib15]). GlyR activation leads to an influx of chloride to hyperpolarize and subsequently inhibit postsynaptic neurons ([@bib2]). Extracellular glycine is transported to the intracellular space by two types of glycine transporters (GLYTs), GLYT1 and GLYT2, which are encoded by two separate genes ([@bib5], [@bib3]). Both GLYTs belong to a large family of Na^+^/Cl^−^-dependent transporter proteins ([@bib18]). GLYT1 and GLYT2 have different functions at glycinergic synapses. GLYT1 eliminates glycine from the synaptic cleft, whereas GLYT2 is essential for glycine uptake into the presynaptic terminal and the subsequent refilling of synaptic vesicles with glycine. Deficiencies of GLYT1 and GLYT2 cause the opposite effects on glycinergic neurotransmission. GLYT1 deficiency causes an increased extracellular glycine, which leads to a sustained activation of GlyRs. This effect generates symptoms found in human glycine encephalopathy. On the other hand, GLYT2 deficiency causes the decreased inhibitory postsynaptic currents via GlyRs and induces human hyperekplexia phenotype *in vivo* ([@bib10], [@bib11], [@bib6], [@bib23], [@bib4]). GLYT1 is predominantly expressed in glial cells of the brain, whereas GLYT2 is specifically expressed in glycinergic neurons and is a reliable marker of glycinergic neurons ([@bib20]).

Genetically modified mice have become a powerful tool in the analysis of neural networks. The Cre/loxP system, in which the Cre recombinase (Cre) transgene activates a reporter gene by inducing recombination at loxP sites, is a widely used approach. In addition, this system facilitates cell-specific gene expression and inactivation in the mouse ([@bib30]). We generated a GLYT2-Cre knock-in mouse line using knock-in techniques to develop a tool for the manipulation of gene expression in glycinergic neurons and the inactivation of the endogenous GLYT2 gene. GLYT2-Cre transgenic mouse lines have been developed using bacterial artificial chromosomes (BACs), which contains more than 100 kb DNA sequences ([@bib13], [@bib8], [@bib22]). BAC-based transgenesis can result in ectopic expression due to the lack of all cis-regulatory elements required for proper expression and random integration into the genome ([@bib12]). We generated a GLYT2-Cre knock-in mouse line expressing Cre under the control of the endogenous GLYT2 promoter using the knock-in strategy to overcome this problem. The knock-in strategy uses homologous recombination in ES cells to insert the Cre into the endogenous gene locus. The knock-in strategy generally captures endogenous gene expression patterns better than BAC transgenic strategies ([@bib12]).

In the present study, we report the generation and characterization of a GLYT2-Cre knock-in mouse line. Cre activity is efficient and restricted to glycinergic neurons in the GLYT2-Cre knock-in mice. The GLYT2-Cre knock-in mouse line is very useful for studies of glycinergic neurons and neurotransmission.

2. Materials and methods {#sec2}
========================

2.1. Mice {#sec2.1}
---------

Two C57BL/6 mouse genomic BAC clones, RP23-83C16 and RP23-155A11 (BACPAC Resources, Oakland, CA, USA), containing the GLYT2 gene were purchased and used to construct the targeting vector. The knock-in vector contained an 8.1 kb fragment from the *Sal*I site (in the 5′-flanking region) to the translation initiation site (in exon 2) of the GLYT2 gene, a Cre cDNA, a polyadenylation signal (pA) from the human granulocyte-colony stimulating factor gene, a phosphoglycerate kinase (PGK) promoter-driven neomycin resistance gene (neo)-pA cassette (PGK-neo-pA cassette) flanked by two frt sites ([@bib28]), a 2.9 kb *Afl*II (in exon 2)-*Nco*I (in intron 2) fragment of the GLYT2 gene, and a MC1 promoter-driven diphtheria toxin A-fragment gene. A 440 bp *Kpn*I (in intron 1b of the GLYT2 gene)-*Age*I (in the Cre gene) fragment was synthesized by two-step PCR to fuse the GLYT2 gene (360 bp) to the Cre gene (80 bp) at their translation initiation sites. The Cre gene was isolated from the Cre-MC vector ([@bib1]). The PGK-neo-pA cassette and the MC1 promoter-driven diphtheria toxin A-fragment gene were isolated from the DT-NeoMC vector ([@bib1]).

The knock-in vector was linearized with *Sal*I and electroporated into the RENKA mouse C57BL/6 ES cell line ([@bib17]). G418-resistant ES clones were isolated and screened using Southern blotting to detect homologous recombination. Genomic DNAs prepared from the ES cell colonies were digested with *Eco*RV and *Eco*RI and were hybridized with the 5′ external probe (Probe A), the 3′ external probe (Probe C), and internal probe (Probe B) (see [Fig. 1](#fig1){ref-type="fig"}). These DNA probes were labeled with digoxigenin using the DIG DNA Labeling Mix, 10x conc. (Roche, Basel, Switzerland). The recombinant ES cells were microinjected into eight cell-stage embryos of the ICR mouse strain to obtain chimeric mice.Fig. 1Generation of the GLYT2-Cre knock-in mouse line. (A) Schematic representations of the wild-type allele (GLYT2^+^), knock-in vector, targeted allele (GLYT2^Crefrtneo^) and modified targeted allele after deletion of the PGK-neo-p(A) cassette (neo) (GLYT2^Cre^). The black numbered boxes represent exons. The black triangle and the gray semicircles represent translation initiation sites and FRT sequences, respectively. The white boxes represent the Cre recombinase gene followed by polyA signal (Cre) and the neo cassette, respectively. The gray box and the line represent the MC1 promoter-driven diphtheria toxin A-fragment gene (DT-A) and the plasmid vector, respectively. The black circles represent the 5′ and 3′ termini of the homologous recombination region in the knock-in targeting vector. The red, green and blue boxes represent the positions of probes A, B and C, respectively. The expected restriction fragment lengths (in kb) for Southern blot analyses are shown. The small black arrows represent the positions of primers P1, P2, P3 and P4 for the PCR analysis. EI, *Eco*RI; EV, *Eco*RV. (**B**) Southern blot analysis of genomic DNA extracted from neomycin-resistant ES cell clones. B6 indicates the negative control. All twelve analyzed clones were correctly targeted. (**C**) PCR analysis of the progeny of GLYT2^Crefrtneo/+^ mice crossed with FLP mice. GLYT2-Cre knock-in (GLYT2^Cre/+^) mice and wild-type (GLYT2^+/+^) mice were obtained. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)Fig. 1

The chimeric mice were crossed with C57BL/6 mice, and mice with germline transmission of the recombined allele were then crossed with FLP66 transgenic mice ([@bib28]) to delete the PGK-neo-pA cassette. GLYT2-Cre knock-in mice were crossed with R26R mice to detect Cre activity ([@bib27]), and GLYT2-Cre/R26R double transgenic (GLYT2^Cre/+^; R26R^lacZ/+^) mice ([@bib31]) were used for histological analyses. GLYT2^+/+^; R26R^lacZ/+^ or GLYT2^+/+^; R26R^+/+^ mice were used as control mice.

All animal procedures were conducted in accordance with the guidelines of the NIH and were reviewed and approved by the Animal Care and Experimentation Committee of Gunma University, Showa Campus (Maebashi, Japan). Every effort was made to minimize the number of animals used and their suffering.

2.2. Genotyping of mutant mice {#sec2.2}
------------------------------

Genotypes of the GLYT2-Cre knock-in mice were determined by PCR using the following oligonucleotides: primer P1 (5′- GGATTGCAGTGCTCCCAAGG-3′), primer P2 (5′- ATCACTCGTTGCATCGACCG-3′), primer P3 (5′-ATCCCTCGATCGAGTGGATC-3′), and primer P4 (5′- GAATCTTGCAGTGCAGAGCG-3′). Primers P1, P2, P3, and P4 correspond to intron 1b and exon 2 of the GLYT2 gene, Cre gene, and PGK-neo-pA cassette, respectively. Primers P1 and P2 amplified a 371 bp fragment specific to the wild-type allele. Primers P1 and P3 amplified a 106 bp fragment specific to the GLYT2-Cre allele and independent of the PGK-neo-pA cassette. Primers P2 and P4 amplified a 169 bp fragment specific to the GLYT2-Cre knock-in allele.

Genotypes of the R26R mice were determined by PCR using the following oligonucleotides: primer R1295 (5′-GCGAAGAGTTTGTCCTCAACC-3′), primer R523 (5′-GGAGCGGGAGAAATGGATATG-3′), and primer R26F2 (5′- AAAGTCGCTCTGAGTTGTTAT-3′) ([@bib24]). Primer R1295 corresponds to the reporter transgene, and primers R523 and R26F2 correspond to the wild-type ROSA26 locus. Primers R523 and R26F2 amplified a 650 bp fragment specific to the wild-type allele. Primers R1295 and R26F2 amplified a 340 bp fragment specific to the mutant allele.

2.3. X-gal staining {#sec2.3}
-------------------

Adult control and GLYT2-Cre/R26R double transgenic mice were decapitated under ether anesthesia, and whole brains were removed. Sagittal brain slices were obtained by cutting the brains into 300 μm thick sections using a microslicer (D.S.K. Super Microslicer Zero 1, Dosaka EM, Kyoto, Japan). The brain slices were fixed with 2% formaldehyde at RT for 15 min. Adult control and mutant mice were transcardially perfused with 4% paraformaldehyde in 0.1 M phosphate buffer (pH 7.4) under ether anesthesia to prepare coronal spinal cord slices. The spinal cords were removed and embedded in Tissue-Tek OCT compound (Sakura Finetek Japan, Tokyo, Japan). The frozen spinal cords were cut into 100 μm thick sections using a cryostat (CM 1510 S, Leica, Nussloch, Germany). These fixed brain and spinal cord slices were washed with PBS and then subjected to X-gal staining (X-Gal Staining Kit, Genlantis, San Diego, USA).

2.4. Combination of fluorescent *in situ* hybridization and immunohistochemistry {#sec2.4}
--------------------------------------------------------------------------------

The 1000-bp cDNA fragment corresponding to nucleotides 1443--2442 of mouse GLYT2 (GenBank accession number [AB118159.1](ncbi-n:AB118159.1){#intref0010}) was amplified by PCR and subcloned into iSiP2 vector to generate the cRNA probe for GLYT2. The plasmids were linearized with the appropriate restriction enzymes and used as templates (2 μg) to synthesize anti-sense or sense cRNA probes for GLYT2 in an in vitro transcription reaction with digoxigenin-11-uridine 5′-triphosphate (DIG RNA labeling kit, Roche Diagnostics, Indianapolis, IN).

Sections of freshly frozen brains from the third postnatal week from control and double heterozygous mice were generated on a cryostat at a thickness of 20 μm. The sections were fixed with 4% paraformaldehyde in 0.1 M phosphate buffer (pH 7.4) for 10 min, washed in phosphate-buffered saline (PBS) containing 2 mg/ml glycine, and acetylated with 0.25% acetic anhydride in 0.1 M triethanolamine for 10 min. After dehydration through a graded ethanol series, the sections were prehybridized for 30 min in a buffer consisting of 50% formamide, 4x SSC, 0.02% Ficoll, 0.02% polyvinylpyrrolidone, 0.02% bovine serum albumin, 1 mM EDTA, 0.1% sodium N-lauroyl sarcosinate, and 200 μg/ml tRNA. Hybridization was performed overnight at 65 °C in prehybridization buffer supplemented with 10% dextran sulfate, 100 mM dithiothreitol, and heat-denatured cRNA probes. On the following day, the sections were washed twice with 5x SSC containing 50% formamide for 30 min, and three times with 2x SSC containing 50% formamide for 30 min at 65 °C.

For the immunodetection of the GLYT2 hybridization signals, the sections were incubated with 0.5% DIG blocking reagent (Roche) in Tris-buffered saline (TBS: 100 mM Tris•HCl \[pH 7.5\] and 150 mM NaCl) for 30 min, followed by 0.5% TSA blocking reagent in TBS containing 0.1% Tween-20 (TBST) for 30 min. The sections were subsequently incubated with a sheep anti-digoxigenin antibody conjugated to polymerized horseradish peroxidase (1:500, anti-digoxigenin-POD, Fab fragments, Roche) in TBST overnight. After extensive washes with TBST, the sections were subjected to tyramide signal amplification with Cy3-tyramide according to the manufacturer\'s instructions (TSA Plus Cy3 system, Perkin-Elmer, Waltham, MA).

For immunodetection of β-galactosidase (β-gal), the sections were subsequently rinsed with PBS, blocked with 5% normal donkey serum in PBS for 30 min, and incubated with a rabbit polyclonal anti-β-galactosidase antibody (5 Prime → 3 Prime, Boulder, CO) overnight at room temperature. Immunoreactions were visualized by incubating the sections with an AlexaFluor 594-conjugated anti-rabbit IgG secondary antibody (Invitrogen, Eugene, OR). Sections were subjected to nuclear staining with 4′,6-diamidino-2-phenylindole dihydrochloride (DAPI) and mounted in Fluormount (Diagnostic Biosystems Inc., Pleasanton, CA).

For the colocalization analysis, fluorescent images (512 × 512 pixels) were captured in various brain regions as single optical slices with a Plan Apochromat objective lens × 20/0.8 using a confocal laser scanning microscope (LSM 710, Carl Zeiss, Jena Germany). Colocalization was evaluated by a visual inspection with the aid of the ZEN2012 software (Carl Zeiss).

3. Results {#sec3}
==========

3.1. Generation of GLYT2-Cre knock-in mice {#sec3.1}
------------------------------------------

The mouse GLYT2 gene encodes three splice variants, GLYT2a, GLYT2b and GLYT2c, which differ in their 5′ regions ([@bib5]). GLYT2b and GLYT2c share the same translation initiation codon (ATG), and it is located in exon 2 of the GLYT2 gene. The translation initiation codon of GLYT2a is located in exon 1a of the GLYT2 gene. GLYT2b and GLYT2c produce proteins with identical amino acid sequences; on the other hand, the N-terminus of the GLYT2a protein is eight amino acids longer than the GLYT2b and GLYT2c proteins. We constructed a targeting vector that placed the Cre gene and the polyadenylation signal of the human granulocyte-colony stimulating factor gene into exon 2 of the GLYT2 gene, in-frame with the first ATG codon ([Fig. 1](#fig1){ref-type="fig"}A). This strategy places the Cre expression cassette under the control of the endogenous GLYT2a, GLYT2b and GLYT2c promoters.

Among the 147 neomycin-resistant ES clones obtained, 40 correctly targeted clones were identified by Southern blot analysis ([Fig. 1](#fig1){ref-type="fig"}B). Fourteen chimeric mice were obtained from twelve targeted ES clones. Germline transmission was confirmed in three chimeric mice derived from the two recombinant targeted ES clones. The germline chimeras were mated to C57BL/6 mice to generate heterozygous mice carrying one Crefrtneo allele (GLYT2^Crefrtneo/+^). The GLYT2^Crefrtneo/+^ mice were crossed with Flp66 transgenic mice ([@bib28]), and the male offspring were mated to C57BL/6 mice to eliminate the PGK-neo cassette from the genome through Flp/frt-mediated excision ([Fig. 1](#fig1){ref-type="fig"}C). The resulting GLYT2^Cre/+^ mice are hereafter referred to as GLYT2-Cre knock-in mice.

3.2. Localization of Cre activity in the GLYT2-Cre knock-in mice {#sec3.2}
----------------------------------------------------------------

We crossed the GLYT2-Cre knock-in mice with R26R mice, a reporter line used to monitor Cre activity ([@bib27]), and produced GLYT2-Cre/R26R double transgenic mice to examine the spatial localization of GLYT2-Cre activity. The R26R mice express β-gal in cells in which the Cre-dependent excision of the floxed stop codon occurs ([@bib27]). Cre recombination was visualized using X-gal staining. Many X-gal-positive cells were present in the brainstem, cerebellum, and spinal cord gray matter of the double transgenic mice, but not in the control mice ([Fig. 2](#fig2){ref-type="fig"}). Glycinergic neurons are largely restricted to these brain regions ([@bib33]). Therefore, Cre is likely expressed in glycinergic neurons in the GLYT2-Cre knock-in mice.Fig. 2Cre-mediated recombination in the GLYT2-Cre knock-in mice. X-gal staining of parasagittal brain sections (**A, B**) and coronal spinal cord sections (**C, D**) from the control (**A, C**) and GLYT2-Cre/R26R double transgenic mice (**B, D**). WM, white matter; GM, gray matter.Fig. 2

Next, we performed immunohistochemistry for β-gal combined with *in situ* hybridization for GLYT2 in the GLYT2-Cre/R26R double transgenic mouse brain to evaluate the specific cell type in which Cre recombination occurred. GLYT2 mRNAs were widely expressed in the brainstem and cerebellar cortex, and the distribution pattern was similar to β-gal ([Fig. 3](#fig3){ref-type="fig"}). Among these regions, the dorsal cochlear nucleus, nucleus of the trapezoid body, and ventral nucleus of lateral lemniscus expressed particularly high levels of the GLYT2 mRNA ([Fig. 3](#fig3){ref-type="fig"}) ([@bib33]). We investigated the colocalization of β-gal and GLYT2 in six brain regions, including the three areas mentioned above. GLYT2 mRNAs were localized in the soma, and it was easy to identify the positive neurons. However, immuno-positive signals for β-gal were not uniformly distributed in the cells but were scattered as small patches ([Fig. 4](#fig4){ref-type="fig"}). More than 98% of the GLYT2 mRNA-expressing cells were positive for β-gal in these brain regions, whereas 90--98% of the β-gal-positive cells expressed GLYT2 mRNAs ([Table 1](#tbl1){ref-type="table"}). One possible explanation for the difference is that β-gal immuno-positive signals were distributed in the proximal neuropil in addition to the soma, whereas GLYT2 mRNAs were restricted to the soma. In summary, Cre activity was undetectable in GLYT2-negative cells, with the exception of the interneurons in the molecular layer of the cerebellar cortex, and almost all glycinergic neurons expressed Cre in the GLYT2-Cre knock-in mice, indicating that the Cre activity is specifically localized to the glycinergic neurons in the GLYT2-Cre knock-in mice.Fig. 3Localization of Cre activity in the GLYT2-Cre knock-in mice. Combined immunohistochemistry for β-gal (red) and *in situ* hybridization for GLYT2 (green) in coronal sections of the brainstem from the GLYT2-Cre/R26R double transgenic mouse. Images in the right columns show the same sections counter-stained with DAPI (blue) as a reference. 4V, fourth ventricle; 7, facial nucleus; 7n, facial nerve; 8n, vestibulocochlear nerve; 12, hypoglossal nucleus; Aq, aqueduct; DC, dorsal cochlear nucleus; DTg, dorsal tegmental nucleus; Gi, gigantocellular reticular nucleus; GiA, gigantocellular reticular nucleus, alpha part; Gr, granular layer; IC, inferior colliculus; icp, inferior cerebellar peduncle; Int, interposed cerebellar nucleus; IO, inferior olive; Lat, lateral cerebellar nucleus; MdD, medullary reticular nucleus, dorsal part; MdV, medullary reticular nucleus, ventral part; Mo, molecular layer; MVe, medial vestibular nucleus; Pa4, paratrochlear nucleus; Pn, pontine nuclei; PnC, pontine reticular nucleus, caudal part; PnO, pontine reticular nucleus, oral part Pr, prepositus nucleus; Pr5, principal sensory trigeminal nucleus; py, pyramidal tract; RMg, raphe magnus nucleus; SC, superior colliculus; SO, superior olive; SP5, spinal trigeminal nucleus; Tz, nucleus of the trapezoid body; VC, ventral cochlear nucleus; VLL, ventral nucleus of the lateral lemniscus. Scale bars, 1 mm. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)Fig. 3Fig. 4Cell type specific localization of Cre activity in the GLYT2-Cre knock-in mice. Combined immunohistochemistry for β-gal (A, D, G, J, M, P) and *in situ* hybridization for GLYT2 (B, E, H, K, N, Q) in the cerebellar cortex (A--C) and various brainstem nuclei, including the spinal trigeminal nucleus (D--F), gigantocellular reticular nucleus (G--I), dorsal cochlear nucleus (J--L), nucleus of the trapezoid body (M--O), and ventral nucleus of lateral lemniscus (P--R), of the GLYT2-Cre/R26R double transgenic mice. Arrows in A-C indicate the coexpression of the β-galactosidase protein and GLYT2 mRNA in Golgi cells. GC, granule cell layer; Mo, molecular layer; PC, Purkinje cell layer. Scale bars, 100 μm.Fig. 4Table 1Colocalization of neurons expressing GLYT2 mRNAs and β-galactosidase in various brain regions.Table 1Brain region% Colocalizationβ-gal(+) neurons in GLYT2 mRNA-expressing neuronsGLYT2 mRNA-expressing neurons in β-gal(+) neuronsCerebellar Golgi cells98.4% (n = 316)93.7% (n = 332)Spinal trigeminal nucleus99.9% (n = 775)96.0% (n = 806)Gigantocellular reticular nucleus100% (n = 466)97.1% (n = 480)Dorsal cochlear nucleus100% (n = 637)97.1% (n = 656)Nucleus of the trapezoid body100% (n = 437)98.4% (n = 444)Ventral nucleus of the lateral lemniscus98.9% (n = 182)90.5% (n = 199)[^1]

4. Discussion {#sec4}
=============

We generated a novel GLYT2-Cre knock-in mouse line and showed that the Cre activity was highly efficient and restricted to glycinergic neurons. The GLYT2-Cre knock-in mice will enable us to specifically manipulate gene expression in glycinergic neurons. The GLYT2-Cre knock-in mice will allow us to develop mice with a deletion of the floxed genes of interest or overexpression of genes using a floxed-stop-transgene strategy specifically in glycinergic neurons, enabling studies of the cellular properties of glycinergic neurons and their functions in the neural network ([@bib9]). Targeting of fluorescent proteins such as EGFP and tdTomato will facilitate the electrophysiological and anatomical characterization of glycinergic neurons ([@bib30]). The GLYT2-Cre knock-in mice will be used in combination with viral vectors carrying floxed opsin genes such as channelrhodopsin-2 and halorhodopsin to enable the genetically driven activation and inactivation of glycinergic neurons ([@bib21], [@bib34]).

Some transgenic mouse lines expressing enhanced green fluorescent protein (EGFP) or Cre under control of the GLYT2 promoter were generated using a BAC system and have contributed to research on glycinergic neurons ([@bib33], [@bib13], [@bib8]). On the other hand, our GLYT2-Cre mouse line was generated using knock-in system. Transgene expression is theoretically controlled by all cis-regulatory elements in knock-in mice, providing a greater ability to recapitulate the endogenous gene expression pattern than BAC transgenic mice ([@bib12]). In fact, nearly 100% of the GLYT2 mRNA-expressing cells were positive for β-gal in our GLYT2-Cre knock-in mouse line ([Table 1](#tbl1){ref-type="table"}). We identified β-gal-positive interneurons in the molecular layer of the cerebellum in adult GLYT2-Cre/R26R double transgenic mice. These observations in the knock-in mice are similar to the observations in the GLYT2-Cre BAC transgenic mice ([@bib13]). Furthermore, EGFP was transiently expressed in molecular interneurons in the cerebellum of the GLYT2-EGFP BAC transgenic mice ([@bib26]). Therefore, the recombination appears to reflect the transient GLYT2-Cre expression in an early developmental period.

Our GLYT2-Cre knock-in mouse line was generated using a gene targeting method. This strategy allowed us to inactivate the GLYT2 gene. Therefore, homozygous GLYT2-Cre knock-in (GLYT2^Cre/Cre^) mice will also be used as GLYT2 knockout mice. Similar to the conventional GLYT2^−/−^ mice ([@bib11]), GLYT2^Cre/Cre^ mice died at approximately postnatal day 14. Researchers have not been able to easily identify the GLYT2-deficient glycinergic neurons with a reduced glycine content ([@bib14]). The expression of the fluorescent protein in glycinergic neurons will allow us to characterize the GLYT2-deficient neurons using the GLYT2^Cre/Cre^ mice that also express a floxed fluorescent protein gene. However, analogous to the conventional GLYT2^+/−^ mice ([@bib11]), GLYT2^Cre/+^ mice were viable and fertile. It has been reported that glycine transport activities in P2 membrane fractions prepared from CNS were not significantly different between heterozygous GlyT2-deficient and wild-type mice ([@bib11]). Furthermore, motor functions of the GLYT2^Cre/+^ mice were not different from those of control wild-type mice ([@bib19]). These results imply that the heterozygous deletion of the GLYT2 gene does not make a drastic impact on glycinergic neurotransmission. Despite the lack of one GLYT2 allele, the GLYT2^Cre/+^ mice are a versatile tool for unraveling the properties of glycinergic neurons and the mechanisms of glycinergic neurotransmission.

5. Conclusions {#sec5}
==============

We have generated a novel GLYT2-Cre knock-in mouse line and have shown that Cre activity is specifically localized in glycinergic neurons. The GLYT2-Cre knock-in mouse line will be a useful tool for manipulating gene expression in glycinergic neurons.
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[^1]: Fluorescent images were acquired with a confocal laser scanning microscope, and the number of labeled neurons was counted by visual inspection.
